Most Asian funds have had a tough time recently, dragged down by their Chinese exposure.
Government intervention in a range of sectors unnerved investors, but now the country has embarked on a new phase of stringent lockdowns in a bid to maintain its zero-Covid policy. Funds dedicated to investing in China have had a torrid time, with JP Morgan China Growth and Income hit especially hard. The Chinese government has reiterated its commitment to its zero-Covid stance, despite the obvious pain that this is inflicting on its economy and the knock-on effect to global supply chains. In that, it has become an outlier. While many other countries in the region were following a simila...
To continue reading this article...
Join Investment Week for free
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes